{"id":"https://openalex.org/W2901902011","doi":null,"title":"Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.","display_name":"Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2901902011","mag":"2901902011","pmid":"https://pubmed.ncbi.nlm.nih.gov/29320594"},"language":"en","primary_location":{"id":"pmid:29320594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29320594","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial, Phase III"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058903008","display_name":"Leon Kircik","orcid":"https://orcid.org/0000-0002-0831-2151","observed_orcids":["https://orcid.org/0000-0002-0831-2151"]},"institutions":[{"id":"https://openalex.org/I4210163856","display_name":"Baumann Cosmetic Dermatology","ror":"https://ror.org/05dayh150","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210163856"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leon H Kircik","raw_affiliation_strings":["Baumann Cosmetic and Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baumann Cosmetic and Research Institute","institution_ids":["https://openalex.org/I4210163856"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091825921","display_name":"Janet C. DuBois","orcid":"https://orcid.org/0000-0002-7487-7716","observed_orcids":["https://orcid.org/0000-0002-7487-7716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet DuBois","raw_affiliation_strings":["Skin Laser and Surgery Specialists of NY and NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Skin Laser and Surgery Specialists of NY and NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040567253","display_name":"Zoe Diana Draelos","orcid":"https://orcid.org/0000-0001-9803-7415","observed_orcids":["https://orcid.org/0000-0001-9803-7415"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zoe Diana Draelos","raw_affiliation_strings":["Henry Ford Health System"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108428454","display_name":"Philip Werschler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109078","display_name":"Center for Dermatology and Laser Surgery","ror":"https://ror.org/01srwdt35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210109078"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Werschler","raw_affiliation_strings":["Center for Dermatology and Laser Surgery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Dermatology and Laser Surgery","institution_ids":["https://openalex.org/I4210109078"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011162470","display_name":"Kimberly Kleveland Grande","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly Grande","raw_affiliation_strings":["Austin Institute for Clinical Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Austin Institute for Clinical Research","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013708358","display_name":"Fran E. Cook-Bolden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fran E Cook-Bolden","raw_affiliation_strings":["Dermatology & Cutaneous Surgery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology & Cutaneous Surgery","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064750087","display_name":"Emily Weng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Weng","raw_affiliation_strings":["Allergan Inc;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan Inc;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109600467","display_name":"David R. Berk","orcid":"https://orcid.org/0009-0009-4852-0287","observed_orcids":["https://orcid.org/0009-0009-4852-0287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R Berk","raw_affiliation_strings":["Allergan Inc;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan Inc;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055721214","display_name":"Gurpreet S. Ahluwalia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gurpreet Ahluwalia","raw_affiliation_strings":["Allergan Inc;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan Inc;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4274,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.92735968,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"17","issue":"1","first_page":"290","last_page":"105"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxymetazoline","display_name":"oxymetazoline","score":0.9300000071525574},{"id":"https://openalex.org/keywords/rosacea","display_name":"rosacea","score":0.9129999876022339},{"id":"https://openalex.org/keywords/facial-erythema","display_name":"facial erythema","score":0.9649999737739563},{"id":"https://openalex.org/keywords/rebound-effect","display_name":"rebound effect","score":0.6850000023841858},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8349999785423279},{"id":"https://openalex.org/keywords/reveal-trial","display_name":"REVEAL trial","score":0.9380000233650208},{"id":"https://openalex.org/keywords/topical-vasoconstrictors","display_name":"topical vasoconstrictors","score":0.621999979019165},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9296590685844421},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.9025225639343262},{"id":"https://openalex.org/C2778081122","wikidata":"https://www.wikidata.org/wiki/Q831530","display_name":"Rosacea","level":3,"score":0.9000641107559204},{"id":"https://openalex.org/C2780042274","wikidata":"https://www.wikidata.org/wiki/Q417813","display_name":"Oxymetazoline","level":4,"score":0.8274321556091309},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7133854031562805},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6845692992210388},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5549192428588867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3063857853412628},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.10741865634918213},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003872","descriptor_name":"Dermatitis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004890","descriptor_name":"Erythema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004890","descriptor_name":"Erythema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010109","descriptor_name":"Oxymetazoline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010109","descriptor_name":"Oxymetazoline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012393","descriptor_name":"Rosacea","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012393","descriptor_name":"Rosacea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063465","descriptor_name":"Skin Cream","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D063465","descriptor_name":"Skin Cream","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:29320594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29320594","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial, Phase III"},{"id":"pmid:29537447","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29537447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:2901902011","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29537447","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2988852302","https://openalex.org/W2787147966","https://openalex.org/W2944552278","https://openalex.org/W4306160469","https://openalex.org/W3024545122","https://openalex.org/W3024172350","https://openalex.org/W4252173820","https://openalex.org/W2998647546","https://openalex.org/W2805767599","https://openalex.org/W2944269696"],"abstract_inverted_index":{"An":[0],"unmet":[1],"need":[2],"exists":[3],"for":[4,10,63,69,97,263],"a":[5,81],"safe,":[6,268],"tolerable,":[7],"effective":[8],"treatment":[9,52],"moderate":[11,43,157,275],"to":[12,44,51,196,258,276],"severe":[13,45,277],"persistent":[14,278],"facial":[15,39,99,279],"erythema":[16,40,127,280],"in":[17,36,200,226,235,272],"patients":[18,37,142,246,273],"with":[19,38,42,53,188,274],"rosacea.":[20,46,282],"This":[21],"pivotal":[22],"phase":[23],"3,":[24,106],"multicenter,":[25],"double-blind":[26],"study":[27,217],"evaluated":[28],"the":[29,88,94,169,215,227,236,259],"efficacy":[30,75,171],"and":[31,66,93,109,123,181,224,232,269],"safety":[32],"of":[33,126,131,140,165,193,241,245,281],"topical":[34],"oxymetazoline":[35,54,166,228],"associated":[41],"Patients":[47],"were":[48,67,149,219],"randomly":[49],"assigned":[50],"hydrochloride":[55],"cream":[56],"1.0%":[57],"or":[58],"vehicle":[59,189,206,237,253],"applied":[60,257],"once":[61,261],"daily":[62,262],"29":[64,264],"days,":[65],"followed":[68],"28":[70],"days":[71,265],"posttreatment.":[72],"The":[73,191,209],"primary":[74,170],"outcome":[76,172],"was":[77,198,266],"having":[78],"at":[79,105,173],"least":[80],"2-grade":[82],"decrease":[83],"from":[84,134],"baseline":[85],"on":[86,113],"both":[87,201],"Clinician":[89],"Erythema":[90],"Assessment":[91],"(CEA)":[92],"Subject":[95],"Self-Assessment":[96],"rosacea":[98],"redness":[100],"(SSA)":[101],"scales":[102],"(composite":[103,128],"success)":[104],"6,":[107],"9,":[108],"12":[110],"hours":[111],"postdose":[112],"day":[114,160],"29.":[115],"Safety":[116],"assessments":[117],"included":[118],"treatment-emergent":[119],"adverse":[120],"events":[121],"(TEAEs)":[122],"posttreatment":[124],"worsening":[125],"CEA/SSA":[129],"increase":[130],"1-grade":[132],"severity":[133],"baseline;":[135],"rebound":[136,248],"effect).":[137],"A":[138],"total":[139],"440":[141],"(mean":[143],"age,":[144],"49.5":[145],"years;":[146],"78.9%":[147],"females)":[148],"randomized":[150],"(oxymetazoline,":[151],"n=222;":[152],"vehicle,":[153],"n=218);":[154],"most":[155,210],"had":[156],"erythema.":[158],"On":[159],"29,":[161],"significantly":[162],"greater":[163],"proportions":[164,244],"recipients":[167],"achieved":[168],"each":[174],"time":[175],"point":[176],"(P":[177,183],"less":[178,184],"than":[179,185],"0.02)":[180],"overall":[182],"0.001)":[186],"compared":[187],"recipients.":[190],"incidence":[192],"discontinuation":[194],"due":[195],"TEAEs":[197,212],"low":[199,243],"groups":[202],"(oxymetazoline":[203,250],"group,":[204,207,251,254],"1.8%;":[205],"0.5%).":[208],"common":[211],"reported":[213],"during":[214],"entire":[216],"period":[218],"application-site":[220,222],"dermatitis,":[221],"erythema,":[223],"headache":[225,233],"group":[229],"(1.4%":[230],"each),":[231],"(0.9%)":[234],"group.":[238],"Following":[239],"cessation":[240],"treatment,":[242],"experienced":[247],"effect":[249],"2.2%;":[252],"1.1%).":[255],"Oxymetazoline":[256],"face":[260],"effective,":[267],"well":[270],"tolerated":[271],"J":[283],"Drugs":[284],"Dermatol.":[285],"2018;17(1):97-105.":[286],".":[287]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-11-29T00:00:00"}